FAS and neoplasm: E09 did not inhibit the growth of grafted tumors unless engineered with ADCC effector function in its Fc (Fig. 6D), confirming the limited direct Fas agonist signaling activation function of E09 antibody against Fas in tumor cell membrane compared to Jurkat cell membrane.